Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial

MLA

Michael McGrath, et al. “Reduced Anticoagulation after Mechanical Aortic Valve Replacement: Interim Results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial Randomized Food and Drug Administration Investigational Device Exemption Trial.” The Journal of Thoracic and Cardiovascular Surgery, vol. 147, Apr. 2014, p. 1202–1211.e2. EBSCOhost, https://doi.org/10.1016/j.jtcvs.2014.01.004.

APA

Michael McGrath, Michael A. Wait, Dennis Nichols, Marc W. Gerdisch, Birger Rhenman, Reed D. Quinn, Chad Hughes, Charles Anderson, John D. Puskas, Tomas D. Martin, Gulshan K. Sethi, Allen Graeve, Bobby Kong, & Lilibeth Fermin. (2014). Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial. The Journal of Thoracic and Cardiovascular Surgery, 147, 1202–1211.e2. https://doi.org/10.1016/j.jtcvs.2014.01.004

Chicago

Michael McGrath, Michael A. Wait, Dennis Nichols, Marc W. Gerdisch, Birger Rhenman, Reed D. Quinn, Chad Hughes, et al. 2014. “Reduced Anticoagulation after Mechanical Aortic Valve Replacement: Interim Results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial Randomized Food and Drug Administration Investigational Device Exemption Trial.” The Journal of Thoracic and Cardiovascular Surgery 147 (April): 1202–1211.e2. doi:10.1016/j.jtcvs.2014.01.004.